NYSE: AREAlexandria Real Estate Equities Inc Stock
$72.66+0.09 (+0.12%)
Updated Apr 30, 2025
ARE Price
$72.66
Fair Value Price
N/A
Market Cap
$12.57B
52 Week Low
$70.57
52 Week High
$130.14
P/E
95.61x
P/B
0.72x
P/S
5.16x
PEG
0.71x
Dividend Yield
5.39%
Revenue
$3.11B
Earnings
$143.47M
Gross Margin
70.5%
Operating Margin
10.93%
Profit Margin
4.2%
Debt to Equity
0.89
Operating Cash Flow
$1B
Beta
0.87
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
ARE Overview
Alexandria Real Estate Equities, Inc. is a real estate investment trust (REIT) that invests in office buildings and laboratories leased to tenants in the life science and technology industries. The company also has a venture capital arm, Alexandria Venture Investments, which invests in life sciences firms. The company was founded in 1994 and is headquartered in Pasadena, CA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ARE's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Office REIT
Industry Rating
F
ARE
Ranked#19 of 20
Ranked#19 of 20
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $13.24 | C | |
| $30.23 | C | |
| $31.51 | C |
Be the first to know about important ARE news, forecast changes, insider trades & much more!
ARE News
Overview
Due Diligence Score
–
Industry Average (22)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ARE scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ARE ($72.66) is trading above its intrinsic value of $40.80, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ARE is poor value based on its earnings relative to its share price (95.61x), compared to the US market average (29.18x)
P/E vs Market Valuation
ARE is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more ARE due diligence checks available for Premium users.
Valuation
ARE price to earnings (PE)
For valuing profitable companies with steady earnings
Company
95.61x
Industry
315.77x
Market
29.18x
ARE is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ARE is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
ARE price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.72x
Industry
0.85x
ARE is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ARE price to earnings growth (PEG)
For valuing profitable companies with growth potential
ARE is good value based... subscribe to Premium to read more.
PEG Value Valuation
ARE's financial health
Profit margin
Revenue
$758.2M
Net Income
-$8.9M
Profit Margin
-1.5%
ARE's Earnings (EBIT) of $339.34M... subscribe to Premium to read more.
Interest Coverage Financials
ARE's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$37.6B
Liabilities
$15.6B
Debt to equity
0.89
ARE's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ARE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$207.9M
Investing
-$654.8M
Financing
$370.8M
ARE's operating cash flow ($1.37B)... subscribe to Premium to read more.
Debt Coverage Financials
ARE vs Office REIT Stocks
Alexandria Real Estate Equities Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.